284 related articles for article (PubMed ID: 28500655)
21. Methylation of Cervical Neoplastic Cells Infected With Human Papillomavirus 16.
Ki EY; Lee KH; Hur SY; Rhee JE; Kee MK; Kang C; Park JS
Int J Gynecol Cancer; 2016 Jan; 26(1):176-83. PubMed ID: 26552048
[TBL] [Abstract][Full Text] [Related]
22. Molecular Triage of Premalignant Lesions in Liquid-Based Cervical Cytology and Circulating Cell-Free DNA from Urine, Using a Panel of Methylated Human Papilloma Virus and Host Genes.
Guerrero-Preston R; Valle BL; Jedlicka A; Turaga N; Folawiyo O; Pirini F; Lawson F; Vergura A; Noordhuis M; Dziedzic A; Pérez G; Renehan M; Guerrero-Diaz C; De Jesus Rodríguez E; Diaz-Montes T; Rodríguez Orengo J; Méndez K; Romaguera J; Trock BJ; Florea L; Sidransky D
Cancer Prev Res (Phila); 2016 Dec; 9(12):915-924. PubMed ID: 27671338
[TBL] [Abstract][Full Text] [Related]
23. Role of genomic DNA methylation in detection of cytologic and histologic abnormalities in high risk HPV-infected women.
Dankai W; Khunamornpong S; Siriaunkgul S; Soongkhaw A; Janpanao A; Utaipat U; Kitkumthorn N; Mutirangura A; Srisomboon J; Lekawanvijit S
PLoS One; 2019; 14(1):e0210289. PubMed ID: 30608989
[TBL] [Abstract][Full Text] [Related]
24. Identification of novel DNA methylation markers in cervical cancer.
Lai HC; Lin YW; Huang TH; Yan P; Huang RL; Wang HC; Liu J; Chan MW; Chu TY; Sun CA; Chang CC; Yu MH
Int J Cancer; 2008 Jul; 123(1):161-7. PubMed ID: 18398837
[TBL] [Abstract][Full Text] [Related]
25. Combined CADM1/MAL methylation and cytology testing for colposcopy triage of high-risk HPV-positive women.
De Strooper LM; Hesselink AT; Berkhof J; Meijer CJ; Snijders PJ; Steenbergen RD; Heideman DA
Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1933-7. PubMed ID: 24962840
[TBL] [Abstract][Full Text] [Related]
26. A four-gene methylation marker panel as triage test in high-risk human papillomavirus positive patients.
Eijsink JJ; Lendvai Á; Deregowski V; Klip HG; Verpooten G; Dehaspe L; de Bock GH; Hollema H; van Criekinge W; Schuuring E; van der Zee AG; Wisman GB
Int J Cancer; 2012 Apr; 130(8):1861-9. PubMed ID: 21796628
[TBL] [Abstract][Full Text] [Related]
27. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
[TBL] [Abstract][Full Text] [Related]
28. Methylation of HPV16 genome CpG sites is associated with cervix precancer and cancer.
Sun C; Reimers LL; Burk RD
Gynecol Oncol; 2011 Apr; 121(1):59-63. PubMed ID: 21306759
[TBL] [Abstract][Full Text] [Related]
29. Genome-wide DNA methylation profiling identifies two novel genes in cervical neoplasia.
El-Zein M; Cheishvili D; Gotlieb W; Gilbert L; Hemmings R; Behr MA; Szyf M; Franco EL;
Int J Cancer; 2020 Sep; 147(5):1264-1274. PubMed ID: 31983058
[TBL] [Abstract][Full Text] [Related]
30. HPV16 CpG methyl-haplotypes are associated with cervix precancer and cancer in the Guanacaste natural history study.
Frimer M; Sun C; McAndrew T; Smith B; Harari A; Chen Z; Mirabello L; Wentzensen N; Goldberg GL; Rodriguez AC; Schiffman M; Burk RD
Gynecol Oncol; 2015 Jul; 138(1):94-100. PubMed ID: 26001326
[TBL] [Abstract][Full Text] [Related]
31. Elevated methylation of HPV16 DNA is associated with the development of high grade cervical intraepithelial neoplasia.
Mirabello L; Schiffman M; Ghosh A; Rodriguez AC; Vasiljevic N; Wentzensen N; Herrero R; Hildesheim A; Wacholder S; Scibior-Bentkowska D; Burk RD; Lorincz AT
Int J Cancer; 2013 Mar; 132(6):1412-22. PubMed ID: 22847263
[TBL] [Abstract][Full Text] [Related]
32. Identification of DNA methylation of SOX9 in cervical cancer using methylated-CpG island recovery assay.
Wu JH; Liang XA; Wu YM; Li FS; Dai YM
Oncol Rep; 2013 Jan; 29(1):125-32. PubMed ID: 23064448
[TBL] [Abstract][Full Text] [Related]
33. Human Papillomavirus DNA Methylation as a Biomarker for Cervical Precancer: Consistency across 12 Genotypes and Potential Impact on Management of HPV-Positive Women.
Clarke MA; Gradissimo A; Schiffman M; Lam J; Sollecito CC; Fetterman B; Lorey T; Poitras N; Raine-Bennett TR; Castle PE; Wentzensen N; Burk RD
Clin Cancer Res; 2018 May; 24(9):2194-2202. PubMed ID: 29420222
[No Abstract] [Full Text] [Related]
34. Correlation between Methylation of Human Papillomavirus-16 L1 Gene and Cervical Carcinoma in Uyghur Women.
Niyazi M; Sui S; Zhu K; Wang L; Jiao Z; Lu P
Gynecol Obstet Invest; 2017; 82(1):22-29. PubMed ID: 26954462
[TBL] [Abstract][Full Text] [Related]
35. Methylation in the promoters of HS3ST2 and CCNA1 genes is associated with cervical cancer in Uygur women in Xinjiang.
Zuo Q; Zheng W; Zhang J; Pan Z; Liu Y; Long H; Fan P; Guo C; Li F; Shao R
Int J Biol Markers; 2014 Dec; 29(4):e354-62. PubMed ID: 25198553
[TBL] [Abstract][Full Text] [Related]
36. Virtues and Weaknesses of DNA Methylation as a Test for Cervical Cancer Prevention.
Lorincz AT
Acta Cytol; 2016; 60(6):501-512. PubMed ID: 27806357
[TBL] [Abstract][Full Text] [Related]
37. DNA methylation markers as triage test for the early identification of cervical lesions in a Chinese population.
Li N; Hu Y; Zhang X; Liu Y; He Y; van der Zee AGJ; Schuuring E; Wisman GBA
Int J Cancer; 2021 Apr; 148(7):1768-1777. PubMed ID: 33300604
[TBL] [Abstract][Full Text] [Related]
38. Reliable identification of women with CIN3+ using hrHPV genotyping and methylation markers in a cytology-screened referral population.
Leeman A; Del Pino M; Marimon L; Torné A; Ordi J; Ter Harmsel B; Meijer CJLM; Jenkins D; Van Kemenade FJ; Quint WGV
Int J Cancer; 2019 Jan; 144(1):160-168. PubMed ID: 30098013
[TBL] [Abstract][Full Text] [Related]
39. Methylation marker analysis of self-sampled cervico-vaginal lavage specimens to triage high-risk HPV-positive women for colposcopy.
Hesselink AT; Heideman DA; Steenbergen RD; Gök M; van Kemenade FJ; Wilting SM; Berkhof J; Meijer CJ; Snijders PJ
Int J Cancer; 2014 Aug; 135(4):880-6. PubMed ID: 24474183
[TBL] [Abstract][Full Text] [Related]
40. Methylation of human papillomavirus type 16 genome and risk of cervical precancer in a Costa Rican population.
Mirabello L; Sun C; Ghosh A; Rodriguez AC; Schiffman M; Wentzensen N; Hildesheim A; Herrero R; Wacholder S; Lorincz A; Burk RD
J Natl Cancer Inst; 2012 Apr; 104(7):556-65. PubMed ID: 22448030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]